Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.669,30
-0,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bio Path Holdings Inc (BPTH) Bio Path Holdings Inc (BPTH) Notizie

Bio Path Holdings Inc

BPTH
2,61
-0,05 (-1,88%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/4/202418:14GLOBEBio-Path Holdings, Inc. Announces Closing of $1.2 Million..
18/4/202419:57GLOBEBio-Path Holdings, Inc. Announces $1.2 Million Registered..
18/4/202413:00GLOBEBio-Path Holdings Announces Successful Completion of Higher..
15/4/202413:00GLOBEBio-Path Holdings Expands Global Patent Portfolio
02/4/202413:00GLOBEBio-Path Holdings Provides 2024 Clinical and Operational..
11/3/202412:00EDGAR2Form 8-K - Current report
08/3/202423:11EDGAR2Form S-1 - General form for registration of securities under..
08/3/202413:10EDGAR2Form 8-K - Current report
08/3/202413:00GLOBEBio-Path Holdings Reports Full Year 2023 Financial Results
08/3/202412:22IHMARKETNEWSU.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil..
07/3/202422:21EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
01/3/202413:00GLOBEBio-Path Holdings to Announce Fourth Quarter and Full Year..
29/2/202412:00EDGAR2Form RW - Registration Withdrawal Request
23/2/202413:01EDGAR2Form 8-K - Current report
21/2/202413:00GLOBEBio-Path Holdings Announces 1-for-20 Reverse Stock Split
02/2/202422:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/2/202422:10EDGAR2Form 8-K - Current report
23/1/202423:20EDGAR2Form 8-K - Current report
23/1/202422:51EDGAR2Form S-1/A - General form for registration of securities..
17/1/202422:52EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/1/202422:10EDGAR2Form 8-K - Current report
10/1/202413:00GLOBEBio-Path Holdings Announces Completion of First Dose Cohort..
04/1/202423:18EDGAR2Form DEF 14A - Other definitive proxy statements
22/12/202322:06EDGAR2Form PRE 14A - Other preliminary proxy statements
22/12/202322:05EDGAR2Form S-1 - General form for registration of securities under..
15/12/202322:05EDGAR2Form 8-K - Current report
14/12/202322:05EDGAR2Form 8-K - Current report
14/12/202313:00GLOBEBio-Path Holdings Successfully Completes First Dose Cohort..
08/12/202322:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/12/202322:05EDGAR2Form 8-K - Current report
15/11/202313:30EDGAR2Form 8-K - Current report
15/11/202313:00GLOBEBio-Path Holdings Reports Third Quarter 2023 Financial..
08/11/202313:00GLOBEBio-Path Holdings to Announce Third Quarter 2023 Financial..
27/10/202322:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/10/202322:30EDGAR2Form DEF 14A - Other definitive proxy statements
24/10/202322:30EDGAR2Form 8-K - Current report
24/10/202313:00GLOBEBio-Path Holdings to Host Virtual Key Opinion Leader Event..
15/9/202322:30EDGAR2Form 8-K - Current report
08/9/202322:01GLOBEBio-Path Holdings to Present at H.C. Wainwright 25th Annual..
15/8/202313:10EDGAR2Form 8-K - Current report
15/8/202313:00GLOBEBio-Path Holdings Reports Second Quarter 2023 Financial..
14/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202313:00GLOBEBio-Path Holdings to Announce Second Quarter 2023 Financial..
07/8/202322:42EDGAR2Form 8-K - Current report
07/8/202313:21EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/8/202313:16EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
03/8/202314:22GLOBEBio-Path Holdings, Inc. Announces Pricing of $2.1 Million..
03/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
01/8/202323:02EDGAR2Form 8-K - Current report
01/8/202322:05EDGAR2Form S-1/A - General form for registration of securities..
Apertura: 2,55 Min: 2,50 Max: 2,82
Chiusura: 2,66

La tua Cronologia

NASDAQ
BPTH
Bio Path
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network